Skip to main content
Signal8

VanEck Pharmaceutical ETF (PPH): ETF

ETF traded on XNAS under symbol PPH. Quoted in usd.

VanEck Pharmaceutical ETF logo

VanEck Pharmaceutical ETF

-0.17%$118.83
XNAS:PPHEquity
AUM $1.07B·YTD --·Yield --
VanEck Pharmaceutical ETF logoXNAS:PPH$118.83-0.17%
About PPH

VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

Largest holdings

  1. LLY Eli Lilly & Co22.44%
  2. MRK Merck & Co Inc12.38%
  3. NVO Novo Nordisk A/S5.47%
  4. MCK Mckesson Corp5.00%
  5. PFE Pfizer Inc4.90%
  6. TEVA Teva Pharmaceutical Industries Ltd4.61%
  7. BMY Bristol-Myers Squibb Co4.53%
  8. COR Cencora Inc4.37%
  9. GSK Gsk Plc4.31%
  10. AZN Astrazeneca Plc3.81%
Full holdings, sectors and countries
Dividend History
Benchmark Comparison
Compared against
Performance Returns
Drawdown Chart
Analyst Coverage
Savings Plan Calculator
Total Invested
$70,000
Final Portfolio
$111,075
Total Return
+$41,075
(+58.7%)
Dividends Reinvested
$0
compounded into portfolio
Defaults are seeded from historical performance and trailing twelve-month yield. Past performance is not a forecast. Feel free to adjust any input to model your own assumptions.
ETF Key Metrics
AUM$1.07B
NAV$118.84
Premium/DiscountAt NAV
Expense Ratio0.36%
Market Cap--
Shares Outstanding--
Inception DateDec. 20, 2011
Fund Details
IssuerVanEck
Asset ClassEquity
Beta--
SectorFinancial Services
DomicileUS
Websitevaneck.com/us/en/investments/pharmaceutical-etf-pph
52-Week Range
$93.11$123.53
Current: $118.83
Volume
Volume292.12K
Avg Volume305.95K
Vol/Avg0.95x

30d

439.16K

60d

373.79K

90d

326.00K

Comparable ETFs